Rune Viig Overgaard

7PUBLICATIONS
11CO-AUTHORS
PharmacogenomicsWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 24, 2026
The Impact of Missed Doses on Pharmacokinetic Concentrations for Oral Semaglutide in Comparison to Other Glucagon-Like Peptide-1-Based Therapies.

|Apr 23, 2026
Efficacy, Safety and PK of Once-Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model-Informed Drug Development Approach.

|Mar 30, 2026
Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.

Anders Strathe, Eric M Bomberg, Garrit Jensch

|Jul 10, 2023
A model-based approach to predict individual weight loss with semaglutide in people with overweight or obesity.

Anders Strathe, Deborah B Horn, Malte Selch Larsen

|May 10, 2021
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials.

Rune V Overgaard, Andrea Navarria, Steen H Ingwersen

|Feb 04, 2020
Impact of dose-escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model-based approach.

Theodoros Papathanasiou, Anders Strathe, Henrik Agersø

Pageof 2

Frequent Collaborators

3 joint publications

Anders Strathe

2 joint publications

Sean Wharton

2 joint publications

Eric M Bomberg

1 joint publications

Rasmus Juul Kildemoes